An Improved Synthesis Route of Molnupiravir and its Key Impurities
Pharmaceutical Fronts · 01.12.2025 · 07 (04) · e357-e362
DOI: 10.1055/a-2735-5050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Fronts, erschienen am 01.12.2025. Verfasst von Guojing Li und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Science and Technology Commission, China State Institute of Pharmaceutical Industry Co., Ltd..
Abstract (Originalsprache)
This paper aims to improve the synthetic process of molnupiravir based on previously reported synthetic routes. The route begins with uracil (ML-2), which is protected with an isopropyl group to yield ML-3 (Step 1), followed by an esterification and a triazolation reaction (Steps 2 and 3) to produce ML-5, which, via a hydroxylation reaction and deprotection (Steps 4 and 5), gives the target product ML-1. Nuclear magnetic resonance (1H NMR) and mass spectra were used for chemical structure identification. There are mainly the following improvements, including: (1) replacing the separate addition of acetone and concentrated H2SO4 with 2,2-dimethoxypropane and catalytic p-toluenesulfonic acid monohydrate in Step 1, simplifying the workup operation and reducing the dosage of reaction solvent. (2) Optimize the synthesis conditions of ML-5, reduce the formation of impurities, and improve the purity of the crude product from 43.12 to 85.21%. (3) Three impurities were isolated, two of which are new compounds. This article lays a foundation to obtain molnupiravir with controllable quality and a stable process for the treatment of coronavirus disease 2019.
Förderung
- Shanghai Science and Technology Commission
- China State Institute of Pharmaceutical Industry Co., Ltd.
Zitieren
APA
Li, G., Du, Z., Gao, X., Chen, D., & Liu, Y. (2025). An Improved Synthesis Route of Molnupiravir and its Key Impurities. Pharmaceutical Fronts, 07(04), e357-e362. https://doi.org/10.1055/a-2735-5050
Vancouver
Li G, Du Z, Gao X, Chen D, Liu Y. An Improved Synthesis Route of Molnupiravir and its Key Impurities. Pharmaceutical Fronts. 2025;07(04):e357-e362. doi:10.1055/a-2735-5050
BibTeX
@article{Li2025,
author = {Li, Guojing and Du, Zhihao and Gao, Xin and Chen, Dongsheng and Liu, Yu},
title = {An Improved Synthesis Route of Molnupiravir and its Key Impurities},
journal = {Pharmaceutical Fronts},
year = {2025},
volume = {07},
number = {04},
pages = {e357--e362},
doi = {10.1055/a-2735-5050}
}
EUVIMED